David Einhorn, who publicly shorted Lehman Brothers stock in the summer of 2008, fought a very public battle against Allied Capital and won big at the 2006 World Series of Poker, is putting some of his chips on Boston Scientific Corp. (NYSE:BSX).
Einhorn, the president of New York-based Greenlight Capital, recently disclosed a more than $300 million stake in the Natick, Mass.-based medical device company, according to filings with the federal Securities and Exchange Commission.
Einhorn bought some 32 million shares in October at an average price of $8.42 per share, according to a letter sent out to shareholders of Greenlight in mid-January.